Pharmacokinetic drug interactions with propranolol

Area of Science:

• Pharmacology
• Drug Metabolism
• Clinical Pharmacy

Background:

• Propranolol is a commonly prescribed medication often used concurrently with other drugs.
• Co-administration can lead to significant drug interactions, affecting the disposition of either propranolol or the co-administered drug.
• These interactions stem from alterations in absorption, metabolism, or hemodynamic factors like liver blood flow.

Purpose of the Study:

• To understand the pharmacokinetic implications of propranolol co-administration.
• To elucidate how other drugs affect propranolol's disposition and vice versa.
• To provide a basis for rational drug use and interpretation of drug effects.

Main Methods:

• Review of existing literature on propranolol pharmacokinetics and drug interactions.
• Analysis of studies investigating the impact of various substances on propranolol absorption, protein binding, and metabolism.
• Examination of propranolol's effects on the pharmacokinetics of other drugs.

Main Results:

• Drug interactions can alter propranolol clearance through induction (e.g., phenytoin, rifampicin) or inhibition (e.g., chlorpromazine, cimetidine) of its metabolism.
• Propranolol can influence the metabolism of other drugs, including theophylline and thyroid hormones.
• Propranolol's effect on liver blood flow may reduce the clearance of high-extraction drugs like lignocaine.

Conclusions:

• Understanding propranolol pharmacokinetics is crucial for managing drug interactions.
• Co-administered drugs can significantly modify propranolol's absorption, metabolism, and clearance.
• Propranolol itself can alter the disposition of other medications, necessitating careful clinical consideration.